Lip Aging
Conditions
Interventions
Phase One (Cross-sectional study) : Young group:None
Phase One (Cross-sectional study) : Middle-aged group:None
Phase One (Cross-sectional study) : Elderly group:None
Phase Two (Interventional Research) : Young Group:From all 80 subjects, 40 were randomly selected for an 8-week clinical trial. Dosage and administration: Apply the product evenly to the lips. Use it
Phase Two (Interventional Research) : Middle-aged Group:From all 80 subjects, 40 were randomly selected for an 8-week clinical trial. Dosage and administration: Apply the product evenly to the lips. U
Phase Two (Intervention Research) : Elderly Group:From all 80 subjects, 40 were randomly selected for an 8-week clinical trial. Dosage and administration: Apply the product evenly to the lips. Use it
Sponsors
Shanghai Skin Disease Hospital
Eligibility
Sex/Gender
Female
Age
20 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.The subjects were Chinese women aged between 20 and 25, 40 and 45, or 60 and 65, with overall good health conditions. 2. The subject has signed the informed consent form and is willing to sign the authorization statement; 3. The subject considers the condition of their lips to be normal to slightly dry. 4. The subjects are reliable and able to follow the instructions; 5. The subjects did not use any lip products within 3 days before the start of the study. 6. The subject is the user and/or recipient of such test products; 7. The subjects held a neutral or favorable attitude towards the fragrance of the product. 8. The subjects agreed to avoid sun exposure and take protective measures to prevent excessive sun exposure (such as using sunscreen, hats, umbrellas, etc. as needed); 9. The subjects agree that during the study period, apart from the designated test products, they will not use any other therapeutic products, nor will they apply any new cosmetic (makeup) products in the test area (lips).
Exclusion criteria
Exclusion criteria: 1.Subject reports being pregnant or nursing; 2.Subject who is currently using, or has routinely used within two weeks prior to study initiation, any systemic or topical corticosteroids, vasoconstrictors, antibiotics, anti-inflammatory medications; 3.Subject has a history of chronic dermatologic, medical, and/or physical conditions, or presently has a dermatologic condition that, in the opinion of the physician(s)or the investigator, might interfere with the conduct of the study, interpretation of results, or increase the risk of adverse reactions (e.g. eczema, psoriasis, rosacea, suspicious lesion, severe acne, rash, broken skin, scar, tattoos, sunburn cold sores/fever blisters more than 2x/year, cracked lips, styes/chalazion more than 2x/year, seborrheic dermatitis, severe dandruff, or skin cancer); 4. Subject who has cold sores, cheilitis, habitual licking, irritation or other chronic medical conditions on the lips within the past 4 weeks; 5. Subject who has a history of adverse reactions to the same type of product as the investigated products; 6. Subject has participated in a clinical or cosmetic study within 1 month of study initiation; 7.Subject has participated in any investigational systemic drug study within two weeks of study initiation; 8. Subject had any facial, lip / perilabial medical treatments and surgery, such as facial peels, photo facials, laser treatment, dermabrasion, botulinum toxin (Botox®), injectable filler treatments, intense pulsed light (IPL), acid treatment, lip fillings, lip injections, lip piercings, lip tattoos, etc., which could influence the outcome of the study, in the past 6 months; 9.Subject with a condition or situation which, in the Investigators opinion, may put the subject at significant risk, may interfere the study results.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lip Plumping;Lip lines; | — |
Countries
China
Contacts
Public ContactTan Yimei
Shanghai Skin Disease Hospital
Outcome results
None listed